Over the past decade, the emergence of cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapies significantly transformed cystic fibrosis (CF) care, and they have become a key area of research1. The gene discussed is CFTR; the disease is cystic fibrosis.